Damiano v. Merck & Co. Inc. et al
| Michele Damiano |
| Merck & Co., Inc. and Merck Sharp & Dohme LLC |
| 3:2023cv00228 |
| April 24, 2023 |
| US District Court for the Western District of North Carolina |
| Charlotte Office |
| Robert J Conrad |
| Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability |
| 28 U.S.C. ยง 1331 Fed. Question: Personal Injury |
| Both |
Docket Report
RSS Track this Docket
This docket was last retrieved on April 24, 2023. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 9 NOTICE of Appearance by Sally Wiest Bryan on behalf of Merck & Co., Inc., Merck Sharp & Dohme LLC (Bryan, Sally) |
| Filing 8 NOTICE of Appearance by Dino S. Sangiamo on behalf of Merck & Co., Inc., Merck Sharp & Dohme LLC (Sangiamo, Dino) |
Filing 7
ORDER of Administrative Close Out of Member Cases. Signed by District Judge Robert J. Conrad, Jr on 9/12/2022. (rth)
|
| Filing 6 Case transferred in from District of New York Southern; Case Number 1:23-cv-02860. Original electronic file and docket sheet received. |
| Case assigned to District Judge Robert J. Conrad, Jr. Notice: You must click this link to retrieve the #Case Assignment Packet. This is your only notice - you will not receive a separate document.(rth) |
| Filing 5 CERTIFIED TRUE COPY OF CONDITIONAL MDL TRANSFER OUT ORDER FROM THE MDL PANEL...transferring this action from the U.S.D.C. - S.D.N.Y to the United States District Court - Western District of North Carolina. (Signed by MDL Panel on 4/17/2023) (vba) [Transferred from New York Southern on 4/24/2023.] |
| MDL TRANSFER OUT ELECTRONICALLY: to the United States District Court - Western District of North Carolina.(vba) [Transferred from New York Southern on 4/24/2023.] |
| Case Designated ECF. (pc) [Transferred from New York Southern on 4/24/2023.] |
| Magistrate Judge Robert W. Lehrburger is so designated. Pursuant to 28 U.S.C. Section 636(c) and Fed. R. Civ. P. 73(b)(1) parties are notified that they may consent to proceed before a United States Magistrate Judge. Parties who wish to consent may access the necessary form at the following link: #https://nysd.uscourts.gov/sites/default/files/2018-06/AO-3.pdf. (pc) [Transferred from New York Southern on 4/24/2023.] |
| CASE OPENING INITIAL ASSIGNMENT NOTICE: The above-entitled action is assigned to Judge Lewis J. Liman. Please download and review the Individual Practices of the assigned District Judge, located at #https://nysd.uscourts.gov/judges/district-judges. Attorneys are responsible for providing courtesy copies to judges where their Individual Practices require such. Please download and review the ECF Rules and Instructions, located at #https://nysd.uscourts.gov/rules/ecf-related-instructions..(pc) [Transferred from New York Southern on 4/24/2023.] |
| Filing 4 RULE 7.1 CORPORATE DISCLOSURE STATEMENT. No Corporate Parent. Document filed by Merck & Co. Inc., Merck Sharp & Dohme LLC..(Possidente, Adam) [Transferred from New York Southern on 4/24/2023.] |
| Filing 3 CIVIL COVER SHEET filed..(Possidente, Adam) [Transferred from New York Southern on 4/24/2023.] |
| Filing 2 DECLARATION of Adam G. Possidente in Support re: #1 Notice of Removal. Document filed by Merck & Co. Inc., Merck Sharp & Dohme LLC. (Attachments: #1 Exhibit A(1) - Plaintiffs Summons and Complaint, dated January 13, 2023 and served on Merck & Co., Inc. on March 8, 2023, #2 Exhibit A(2) - Plaintiffs Summons and Complaint, dated January 13, 2023 and served on Merck Sharp & Dohme LLC on March 8, 2023, #3 Exhibit B - Cleveland Clinic, Postural Orthostatic Tachycardia Syndrome (POTS), #4 Exhibit C - Cleveland Clinic, Autonomic Neuropathy or Autonomic Dysfunction (Syncope): Information and Instructions, #5 Exhibit D - National Institutes of Health, National Cancer Institute, HPV Vaccines, #6 Exhibit E - 9/12/2008 FDA Approval Letter for Gardasil, #7 Exhibit F - 10/16/2009 FDA Approval Letter for Gardasil, #8 Exhibit G - 12/22/2010 FDA Approval Letter for Gardasil, #9 Exhibit H - 12/10/2014 FDA Approval Letter for Gardasil 9, #10 Exhibit I - 12/14/2015 FDA Approval Letter for Gardasil 9, #11 Exhibit J - 10/5/2018 FDA Approval Letter for Gardasil 9, #12 Exhibit K - 6/12/2020 FDA Approval Letter for Gardasil 9, #13 Exhibit L - Centers for Disease Control and Prevention (CDC), Cancers Associated with Human Papillomavirus (HPV), #14 Exhibit M - CDC, Human Papillomavirus (HPV) Vaccination & Cancer Prevention, #15 Exhibit N - FDA, Gardasil Vaccine Safety, #16 Exhibit O - CDC, Human Papillomavirus (HPV) Vaccine, #17 Exhibit P - CDC, HPV Vaccine Recommendations, #18 Exhibit Q - FDA Commissioner Stephen M. Hahn, The FDAs Scientific and Regulatory Oversight of Vaccines Is Vital to Public Health, #19 Exhibit R - CDC, HPV Vaccine Safety and Effectiveness Data, #20 Exhibit S - CDC, Questions about HPV Vaccine Safety, #21 Exhibit T - World Health Organization, Safety Update of HPV Vaccines, #22 Exhibit U - European Medicines Agency, Review Concludes Evidence Does Not Support that HPV Vaccines Cause CRPS or POTS, #23 Exhibit V - Joint Statement on the Elimination of HPV, #24 Exhibit W - CDC, Adjuvants and Vaccines, #25 Exhibit X - FDA, FDA Information on Gardasil Presence of DNA Fragments Expected, No Safety Risk, #26 Exhibit Y - CBER, Compliance Manual, Inspection of Biological Drug Products, 7345.848).(Possidente, Adam) [Transferred from New York Southern on 4/24/2023.] |
| Filing 1 NOTICE OF REMOVAL from Supreme Court of the State of New York, County of New York. Case Number: 150432/2023. (Filing Fee $ 402.00, Receipt Number ANYSDC-27568397).Document filed by Merck Sharp & Dohme LLC, Merck & Co. Inc...(Possidente, Adam)[Transferred from New York Southern on 4/24/2023.] |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
